EMMAC announced that Malta Enterprise, the Maltese government's exclusive agency focused on attracting inward investment and supporting enterprise in Malta, has granted EMMAC a Letter of Intent under terms of the Production of Cannabis for Medicinal Use Act, 2018, Chapter 578 of the Laws of Malta. The Letter of Intent is preliminary approval for the issuance of a full license (covering cultivation / production / importation / exportation) under the terms of the Production of Cannabis for Medicinal Use Act, 2018.
The Turnkey GMP facility in Malta will be EMMAC’s importation, exportation, testing and distribution hub for Europe and other international markets.
“We are delighted to have had such strong support from the Maltese Government and relevant public and regulatory authorities,” Antonio Costanzo, CEO of EMMAC, said. “As the demand for premium quality medical cannabis continues to grow, our facility in Malta will form a critical part of EMMAC’s unique European infrastructure as our group import and distribution hub.”